Abstract
Unlike many other malignancies, overall survival for women with epithelial ovarian cancer has improved only modestly over the last half-century. The perspectives presented here detail the views of a gynecologic oncologist looking back and the view of the academic editor looking forward. Surgical beginnings in 1809 are merged with genomics, surgical advances, and precision therapy at present and for the future. Presentations in this special issue focus on factors related to the diagnosis of ovarian cancer: (1) markers for the preoperative assessment of primary and metastatic ovarian tumors, (2) demonstrations of the presence of pelvic fluid in ultrasound studies of ovarian malignancies, (3) the effects of age, menopausal status, and body habitus on ovarian visualization, (4) the ability of OVA1 to detect ovarian cancers when Ca125 was not informative, (5) the detection of tumor-specific changes in cell adhesion molecules by tissue-based staining, (6) presentation of a high discrimination model for ovarian cancer using IOTA Simple Rules and CA125, (7) review of low-grade serous carcinoma of the ovary, and (8) a comprehensive case report on ovarian carcinosarcoma.
| Original language | English |
|---|---|
| Article number | 791 |
| Journal | Diagnostics |
| Volume | 12 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2022 |
Bibliographical note
Publisher Copyright:© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Funding
Funding: This effort was funded by the Kentucky Department of Health and Human Services, grant number 202007161438, and the Telford Foundation.
| Funders | Funder number |
|---|---|
| Telford Foundation | |
| North Carolina Department of Health and Human Services | 202007161438 |
Keywords
- CAR T cell therapies
- HIPEC
- PARP inhibitors
- genomics
- immunotherapy
- interval debulking
- liquid biopsy
- neoadjuvant chemotherapy
- ovarian cancer
- prevention
- surgery at relapse
- surgical debulking
- ultra-radical surgery
ASJC Scopus subject areas
- Clinical Biochemistry
